All tenders
75F40121C00127
EVALUATING THE IMPACT OF EXTENDED-INFUSION BETA-LACTAM ADMINISTRATION STRATEGIES ON IMPROVING CLINICAL OUTCOMES AND REDUCING THE SUBSEQUENT EMERGENCE OF ANTIMICROBIAL RESISTANCE-BAA-PMWP#173.
Food and Drug Administration · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedHealthcare & MedicalFederal
Basic information
- Reference number
- 75F40121C00127
- Issuing organization
- Food and Drug Administration · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- EVALUATING THE IMPACT OF EXTENDED-INFUSION BETA-LACTAM ADMINISTRATION STRATEGIES ON IMPROVING CLINICAL OUTCOMES AND REDUCING THE SUBSEQUENT EMERGENCE OF ANTIMICROBIAL RESISTANCE-BAA-PMWP#173.
- Source
- USASpending (Federal)
- Source ID
- usa-75F40121C00127
Details
- Location
- United States
Description
EVALUATING THE IMPACT OF EXTENDED-INFUSION BETA-LACTAM ADMINISTRATION STRATEGIES ON IMPROVING CLINICAL OUTCOMES AND REDUCING THE SUBSEQUENT EMERGENCE OF ANTIMICROBIAL RESISTANCE-BAA-PMWP#173. Awarded to: THE JOHNS HOPKINS UNIVERSITY Agency: Department of Health and Human Services Sub-agency: Food and Drug Administration Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2021/09/27 12:00:00 AM UTC
- Closing date
- 2023/09/28 12:00:00 AM UTC
Estimated value
$307K USD
Classification
Normalized category
Healthcare & Medical